These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17542446)

  • 21. Hepatitis C virus seroprevalence: selected health care settings in Texas.
    Melville SK; Heseltine G; Delamater E; Gilani Z; Hendricks K; Suarez L
    Tex Med; 2006 Mar; 102(3):56-61. PubMed ID: 17115588
    [No Abstract]   [Full Text] [Related]  

  • 22. Seroepidemiology of viral infections among intravenous drug users in northern California.
    Zeldis JB; Jain S; Kuramoto IK; Richards C; Sazama K; Samuels S; Holland PV; Flynn N
    West J Med; 1992 Jan; 156(1):30-5. PubMed ID: 1310362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites.
    Smith BD; Teshale E; Jewett A; Weinbaum CM; Neaigus A; Hagan H; Jenness SM; Melville SK; Burt R; Thiede H; Al-Tayyib A; Pannala PR; Miles IW; Oster AM; Smith A; Finlayson T; Bowles KE; Dinenno EA
    Clin Infect Dis; 2011 Oct; 53(8):780-6. PubMed ID: 21921221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of human immunodeficiency virus, hepatitis C virus, hepatitis B virus and syphilis among individuals attending anonymous testing for HIV in Luanda, Angola.
    Guimarães Nebenzahl H; Lopes A; Castro R; Pereira F
    S Afr Med J; 2013 Jan; 103(3):186-8. PubMed ID: 23472697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C virus coinfection in a cohort of HIV-infected individuals from Santos, Brazil: seroprevalence and associated factors.
    Segurado AC; Braga P; Etzel A; Cardoso MR
    AIDS Patient Care STDS; 2004 Mar; 18(3):135-43. PubMed ID: 15104874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low rates of hepatitis C testing among people who inject drugs in Thailand: implications for peer-based interventions.
    Ti L; Kaplan K; Hayashi K; Suwannawong P; Wood E; Kerr T
    J Public Health (Oxf); 2013 Dec; 35(4):578-84. PubMed ID: 23335599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and genotypes of hepatitis C virus infection among drug addicts and blood donors in Thailand.
    Verachai V; Phutiprawan T; Theamboonlers A; Chinchai T; Tanprasert S; Haagmans BL; Osterhaus AD; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2002 Dec; 33(4):849-51. PubMed ID: 12757237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrating care for hepatitis C virus (HCV) and primary care for HIV for injection drug users coinfected with HIV and HCV.
    Kresina TF; Bruce RD; Cargill VA; Cheever LW
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S83-8. PubMed ID: 16265621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
    Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B
    Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The urgent need for HIV and hepatitis prevention in drug treatment programs in Hungary.
    Gyarmathy VA; Rácz J; Neaigus A; Ujhelyi E
    AIDS Educ Prev; 2004 Jun; 16(3):276-87. PubMed ID: 15237056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High uptake of hepatitis C virus treatment in HIV/hepatitis C virus co-infected patients attending an integrated HIV/hepatitis C virus clinic.
    Kieran J; Dillon A; Farrell G; Jackson A; Norris S; Mulcahy F; Bergin C
    Int J STD AIDS; 2011 Oct; 22(10):571-6. PubMed ID: 21998177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human immunodeficiency virus and hepatitis C virus testing services at syringe exchange programs: availability and outcomes.
    Heinzerling KG; Kral AH; Flynn NM; Anderson RL; Scott A; Gilbert ML; Asch SM; Bluthenthal RN
    J Subst Abuse Treat; 2007 Jun; 32(4):423-9. PubMed ID: 17481466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C virus antibody prevalence among injecting drug users in Glasgow has fallen but remains high.
    Goldberg D; Cameron S; McMenamin J
    Commun Dis Public Health; 1998 Jun; 1(2):95-7. PubMed ID: 9644121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Epidemiology of hepatitis C and human immunodeficiency virus infections among injecting drug users in Hungary--what's next?].
    Gyarmathy VA; Rácz J
    Orv Hetil; 2010 Mar; 151(10):365-71. PubMed ID: 20178967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A missed opportunity: hepatitis C screening of prisoners.
    Macalino GE; Dhawan D; Rich JD
    Am J Public Health; 2005 Oct; 95(10):1739-40. PubMed ID: 16186452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of HIV, HCV, and High-Risk Behaviors for Substance Users in Drop in Centers in Southern Iran.
    Salehi A; Naghshvarian M; Marzban M; Bagheri Lankarani K
    J Addict Med; 2015; 9(3):181-7. PubMed ID: 25748560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of human immunodeficiency virus (HIV), hepatitis B virus, and hepatitis C virus in three groups of populations at high risk of HIV infection in Amritsar (Punjab), Northern India.
    Jindal N; Arora U; Singh K
    Jpn J Infect Dis; 2008 Jan; 61(1):79-81. PubMed ID: 18219142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C Prevention and Needle Exchange Programs in Rhode Island: ENCORE.
    Joseph R; Kofman A; Larney S; Fitzgerald P
    R I Med J (2013); 2014 Jul; 97(7):31-4. PubMed ID: 24983019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An urgent need to scale-up injecting drug harm reduction services in Tanzania: prevalence of blood-borne viruses among drug users in Temeke District, Dar-es-Salaam, 2011.
    Bowring AL; Luhmann N; Pont S; Debaulieu C; Derozier S; Asouab F; Toufik A; van Gemert C; Dietze P; Stoove M
    Int J Drug Policy; 2013 Jan; 24(1):78-81. PubMed ID: 23036650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Injection drug users and the provision of hepatitis C-related services in a nationwide sample of drug treatment programs.
    Vassilev ZP; Strauss SM; Astone J; Des Jarlais DC
    J Behav Health Serv Res; 2004; 31(2):208-16. PubMed ID: 15255228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.